Epidemiology, Screening, and Prevention of Bladder Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Epidemiology, Screening, and Prevention of Bladder Cancer

Published:2022-12 Issue:6 Volume:5 Page:628-639
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Lobo Niyati,Afferi Luca,Moschini Marco,Mostafid Hugh,Porten Sima,Psutka Sarah P.,Gupta Shilpa,Smith Angela B.,Williams Stephen B.,Lotan Yair

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference137 articles.

1. GLOBOCAN 2020 v1.0: cancer incidence and mortality worldwide;Global Cancer Observatory,2021

2. Bladder cancer in Africa;Heyns;Can J Urol,2008

3. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy;van Rhijn;Eur Urol,2009

4. Quality of life after bladder cancer: a cross-sectional survey of patient-reported outcomes;Catto;Eur Urol,2021

5. The economics of bladder cancer: costs and considerations of caring for this disease;Svatek;Eur Urol,2014

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary Free Glycosaminoglycans Identify Adults at High Risk of Developing Early-stage High-grade Bladder Cancer;European Urology Open Science;2024-10

2. Cost-effectiveness of nivolumab plus gemcitabine-cisplatin as first-line treatment for advanced urothelial carcinoma in China and the United States;Frontiers in Immunology;2024-09-13

3. First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer;Journal of Clinical Oncology;2024-09-06

4. DGKZ Promotes Tumor Progression in Bladder Cancer Cells by Modulating Phosphatidic Acid Biosynthesis through Interaction with CEBPZ Protein;2024-08-28

5. Observational study of in-hospital mortality risk from bladder cancer: Five years of experience at a tertiary referral hospital in Indonesia;Medicine;2024-08-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3